IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,421 | +11.3% | 9,489 | +0.7% | 0.00% | – |
| Q2 2023 | $386,749 | -76.3% | 9,426 | -79.4% | 0.00% | -100.0% |
| Q1 2023 | $1,634,246 | -35.1% | 45,726 | -31.4% | 0.00% | 0.0% |
| Q4 2022 | $2,516,426 | -13.0% | 66,625 | +1.8% | 0.00% | -50.0% |
| Q3 2022 | $2,894,000 | +140.6% | 65,426 | +101.5% | 0.00% | +100.0% |
| Q2 2022 | $1,203,000 | -2.7% | 32,465 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $1,236,000 | +188.8% | 33,362 | +136.8% | 0.00% | – |
| Q4 2021 | $428,000 | -75.0% | 14,087 | -72.3% | 0.00% | -100.0% |
| Q3 2021 | $1,709,000 | -81.7% | 50,946 | -78.3% | 0.00% | -80.0% |
| Q2 2021 | $9,350,000 | +29.5% | 234,386 | +46.0% | 0.01% | +25.0% |
| Q1 2021 | $7,218,000 | -18.1% | 160,567 | +3.0% | 0.00% | -20.0% |
| Q4 2020 | $8,810,000 | -28.5% | 155,823 | -40.0% | 0.01% | -37.5% |
| Q3 2020 | $12,320,000 | +16.4% | 259,617 | +44.6% | 0.01% | 0.0% |
| Q2 2020 | $10,585,000 | +51.2% | 179,545 | +21.2% | 0.01% | +33.3% |
| Q1 2020 | $7,002,000 | -65.6% | 148,130 | -56.0% | 0.01% | -53.8% |
| Q4 2019 | $20,330,000 | +72.2% | 336,582 | +70.8% | 0.01% | +62.5% |
| Q3 2019 | $11,803,000 | -80.3% | 197,069 | -78.9% | 0.01% | -77.1% |
| Q2 2019 | $59,942,000 | +619.2% | 932,733 | +808.0% | 0.04% | +600.0% |
| Q1 2019 | $8,335,000 | +180.5% | 102,719 | +86.8% | 0.01% | +150.0% |
| Q4 2018 | $2,971,000 | -74.4% | 54,997 | -75.5% | 0.00% | -33.3% |
| Q3 2018 | $11,584,000 | -36.9% | 224,628 | -49.0% | 0.00% | -40.0% |
| Q2 2018 | $18,355,000 | +16.8% | 440,582 | +23.6% | 0.01% | -28.6% |
| Q1 2018 | $15,714,000 | +81.6% | 356,560 | +107.2% | 0.01% | +16.7% |
| Q4 2017 | $8,653,000 | -87.3% | 172,113 | -87.2% | 0.01% | -87.2% |
| Q3 2017 | $68,022,000 | +179.2% | 1,341,733 | +180.1% | 0.05% | +176.5% |
| Q2 2017 | $24,360,000 | +14.0% | 478,939 | -10.0% | 0.02% | +6.2% |
| Q1 2017 | $21,376,000 | -37.1% | 531,872 | -25.2% | 0.02% | -40.7% |
| Q4 2016 | $33,986,000 | +17.8% | 710,620 | -9.8% | 0.03% | +35.0% |
| Q3 2016 | $28,851,000 | +11.7% | 787,515 | -29.0% | 0.02% | +11.1% |
| Q2 2016 | $25,833,000 | -15.9% | 1,109,350 | +46.2% | 0.02% | -21.7% |
| Q1 2016 | $30,721,000 | -28.8% | 758,626 | +8.9% | 0.02% | -23.3% |
| Q4 2015 | $43,142,000 | – | 696,674 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |